comparemela.com

Latest Breaking News On - Davidl spector - Page 1 : comparemela.com

Amaroq Therapeutics hits early milestones in cancer treatment

NZ biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase.

Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board

Gene-regulating snippet of RNA may contribute to breast cancer metastasis

Gene-regulating snippet of RNA may contribute to breast cancer metastasis Cold Spring Harbor Laboratory (CSHL) scientists have discovered a gene-regulating snippet of RNA that may contribute to the spread of many breast cancers. In animal experiments, the researchers could reduce the growth of metastatic tumors with a molecule designed to target that RNA and trigger its destruction. The same strategy, they say, could be used to develop a new breast cancer treatment for patients. The study, led by CSHL Professor and Director of Research David Spector, was reported in the journal Nature Communications. In 2016, Spector and colleagues identified dozens of RNA molecules that were more prevalent in breast cancer cells than in noncancerous cells of the same type. All were long, non-coding RNAs (lncRNAs) RNA molecules that do not encode proteins and are thought to play various regulatory roles inside cells. The current study investigated how one of these, Mammary Tumor-Associated RNA 25

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.